InvestorsObserver is giving Jasper Therapeutics Inc (JSPR) an Analyst Rating Rank of 74, meaning JSPR is ranked higher by analysts than 74% of stocks. The average price target for JSPR is $20 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating JSPR a Strong Buy today. Find out what this means to you and get the rest of the rankings on JSPR!